JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CTO
4801
CTO Realty Growth
CTO
$761M
| $83K | ﹤0.01% |
5,135
+1,668
| +48% | +$27.3K |
2017 Q4
6 quarters
|
|
|
KRSA
4802
Korsana Biosciences, Inc. Common Stock
KRSA
$1.4B
| $83K | ﹤0.01% |
+53
| New | +$105K |
2019 Q2
0 quarters
|
|
4803
Limoneira
LMNR
$217M
| $83K | ﹤0.01% |
4,296
+668
| +18% | +$14.3K |
2017 Q4
6 quarters
|
|
4804
Universal Logistics Holdings
ULH
$465M
| $83K | ﹤0.01% |
3,778
+1,750
| +86% | +$37.4K |
2013 Q2
24 quarters
|
|
|
ABDC
4805
DELISTED
Alcentra Capital Corp
ABDC
| $83K | ﹤0.01% |
9,837
-206
| -2% | -$1.7K |
2019 Q1
1 quarter
|
|
|
CLLS
4806
Cellectis
CLLS
$142M
| $82K | ﹤0.01% |
5,348
-61,953
| -92% | -$1.11M |
2017 Q3
7 quarters
|
|
|
CSLT
4807
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $82K | ﹤0.01% |
27,652
+8,491
| +44% | +$29.2K |
2017 Q4
6 quarters
|
|
4808
American Coastal Insurance
ACIC
$439M
| $81K | ﹤0.01% |
5,664
-52,775
| -90% | -$787K |
2017 Q2
8 quarters
|
|
4809
Primis Financial Corp
FRST
$385M
| $81K | ﹤0.01% |
5,414
-44
| -0.8% | -$649 |
2016 Q1
13 quarters
|
|
4810
Peoples Financial Services
PFIS
$692M
| $81K | ﹤0.01% |
1,893
+212
| +13% | +$9.27K |
2017 Q4
6 quarters
|
|
4811
Epsilon Energy
EPSN
$184M
| $80K | ﹤0.01% |
20,550
+50
| +0.2% | +$209 |
2019 Q1
1 quarter
|
|
|
GIFI
4812
DELISTED
Gulf Island Fabrication
GIFI
| $80K | ﹤0.01% |
11,087
-6,159
| -36% | -$50.8K |
2014 Q2
20 quarters
|
|
|
SACH
4813
Sachem Capital Corp
SACH
$43.2M
| $80K | ﹤0.01% |
+15,000
| New | +$72.6K |
2019 Q2
0 quarters
|
|
4814
Dianthus Therapeutics
DNTH
$4.92B
| $79K | ﹤0.01% |
334
+115
| +53% | +$28.4K |
2018 Q3
3 quarters
|
|
4815
Farmers & Merchants Bancorp
FMAO
$487M
| $79K | ﹤0.01% |
2,769
+565
| +26% | +$16.9K |
2017 Q4
6 quarters
|
|
4816
Xeris Biopharma Holdings
XERS
$1.85B
| $79K | ﹤0.01% |
7,324
-2,119
| -22% | -$22.2K |
2018 Q3
3 quarters
|
|
|
CDMO
4817
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $79K | ﹤0.01% |
19,682
-109,519
| -85% | -$452K |
2015 Q1
17 quarters
|
|
|
RESP
4818
DELISTED
WisdomTree U.S. ESG Fund
RESP
| $79K | ﹤0.01% |
2,373
| – | – |
2018 Q2
4 quarters
|
|
4819
Quince Therapeutics
QNCX
$28.6M
| $78K | ﹤0.01% |
+10
| New | +$59.7K |
2019 Q2
0 quarters
|
|
|
DVAX
4820
DELISTED
Dynavax Technologies
DVAX
| $77K | ﹤0.01% |
19,974
-249,566
| -93% | -$1.45M |
2016 Q3
11 quarters
|
|
4821
Lands' End
LE
$314M
| $77K | ﹤0.01% |
6,193
+1,255
| +25% | +$19K |
2015 Q4
14 quarters
|
|
4822
SEACOR Marine Holdings
SMHI
$236M
| $76K | ﹤0.01% |
5,292
+648
| +14% | +$8.93K |
2017 Q2
8 quarters
|
|
|
CUTR
4823
DELISTED
Cutera, Inc.
CUTR
| $76K | ﹤0.01% |
3,798
+483
| +15% | +$8.63K |
2016 Q4
10 quarters
|
|
4824
iShares Core Moderate Allocation ETF
AOM
$1.91B
| $75K | ﹤0.01% |
1,920
+805
| +72% | +$30.8K |
2016 Q2
12 quarters
|
|
|
CDTX
4825
DELISTED
Cidara Therapeutics
CDTX
| $75K | ﹤0.01% |
2,393
-379
| -14% | -$15.7K |
2016 Q1
13 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.